Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:MYO NASDAQ:TELA OTCMKTS:UEEC NASDAQ:ZYXI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMYOMyomo$1.87-3.1%$2.41$1.83▼$7.17$69.44M1.4407,453 shs331,230 shsTELATELA Bio$1.86+9.4%$1.83$0.86▼$4.39$67.24M0.9356,505 shs96,274 shsUEECUnited Health Products$0.08-8.6%$0.12$0.05▼$0.28$23.06M-1.56141,497 shs34,000 shsZYXIZynex$1.26-43.5%$2.34$1.23▼$9.42$67.43M0.91129,129 shs2.27 million shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMYOMyomo-3.11%-11.37%-10.10%-61.68%-64.24%TELATELA Bio+9.41%-3.12%-2.62%+82.35%-58.20%UEECUnited Health Products-8.57%-2.15%-17.82%-67.07%-51.71%ZYXIZynex-43.50%-51.16%-53.16%-45.45%-86.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMYOMyomo2.0796 of 5 stars3.52.00.00.00.62.50.6TELATELA Bio2.3241 of 5 stars3.44.00.00.00.61.70.6UEECUnited Health Products0.0808 of 5 stars0.03.00.00.00.60.00.0ZYXIZynex2.5642 of 5 stars3.22.00.00.01.61.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMYOMyomo 3.00Buy$9.67416.93% UpsideTELATELA Bio 2.75Moderate Buy$7.25289.78% UpsideUEECUnited Health Products 0.00N/AN/AN/AZYXIZynex 2.33Hold$4.90288.89% UpsideCurrent Analyst Ratings BreakdownLatest UEEC, ZYXI, TELA, and MYO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/1/2025ZYXIZynexLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$3.708/1/2025ZYXIZynexHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral7/15/2025ZYXIZynexRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform ➝ Sector Perform$4.00 ➝ $3.006/30/2025ZYXIZynexHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$8.006/26/2025MYOMyomoAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy6/23/2025MYOMyomoCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$10.00 ➝ $8.006/5/2025MYOMyomoAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$11.00 ➝ $11.505/8/2025MYOMyomoCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$11.00 ➝ $10.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMYOMyomo$32.55M2.07N/AN/A$0.82 per share2.28TELATELA Bio$69.30M1.06N/AN/A$0.72 per share2.58UEECUnited Health Products$40K527.00N/AN/A($0.01) per share-8.21ZYXIZynex$192.35M0.20$0.14 per share9.13$1.12 per share1.13Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMYOMyomo-$6.18M-$0.23N/AN/AN/A-15.05%-35.57%-20.11%8/5/2025 (Estimated)TELATELA Bio-$37.84M-$1.41N/AN/AN/A-61.00%-402.45%-62.73%8/11/2025 (Estimated)UEECUnited Health Products-$2M-$0.02N/A∞N/AN/AN/A-1,905.82%N/AZYXIZynex$2.99M-$0.24N/A2.68N/A-19.79%-59.71%-15.57%N/ALatest UEEC, ZYXI, TELA, and MYO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2025Q2 2025TELATELA Bio-$0.18N/AN/AN/A$20.67 millionN/A8/5/2025Q2 2025MYOMyomo-$0.11N/AN/AN/A$9.15 millionN/A5/8/2025Q1 2025TELATELA Bio-$0.21-$0.25-$0.04-$0.25$17.35 million$18.52 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMYOMyomoN/AN/AN/AN/AN/ATELATELA BioN/AN/AN/AN/AN/AUEECUnited Health ProductsN/AN/AN/AN/AN/AZYXIZynexN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMYOMyomoN/A2.662.37TELATELA Bio2.284.223.40UEECUnited Health ProductsN/A0.020.02ZYXIZynex2.873.462.63Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMYOMyomo44.99%TELATELA Bio94.35%UEECUnited Health Products0.07%ZYXIZynex29.68%Insider OwnershipCompanyInsider OwnershipMYOMyomo4.79%TELATELA Bio4.70%UEECUnited Health Products1.50%ZYXIZynex49.28%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMYOMyomo9035.98 million34.26 millionNot OptionableTELATELA Bio12039.56 million37.70 millionOptionableUEECUnited Health Products4256.76 million252.91 millionNot OptionableZYXIZynex77030.24 million15.34 millionOptionableUEEC, ZYXI, TELA, and MYO HeadlinesRecent News About These CompaniesZynex, Inc. (NASDAQ:ZYXI) Q2 2025 Earnings Call Transcript1 hour ago | msn.comHC Wainwright & Co. Downgrades Zynex (ZYXI)1 hour ago | msn.comZynex, Inc.: Zynex Reports Second Quarter 2025 Financial ResultsAugust 1 at 6:12 AM | finanznachrichten.deZynex Inc (ZYXI) Q2 2025 Earnings Report Preview: What to Look ForAugust 1 at 2:11 AM | finance.yahoo.comZynex, Inc. (ZYXI) Q2 2025 Earnings Call TranscriptJuly 31 at 9:01 PM | seekingalpha.comZynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue EstimatesJuly 31 at 6:36 PM | zacks.comZynex eyes growth revival under new CEO, advances oximeter technologyJuly 31 at 4:26 PM | proactiveinvestors.comZynex Reports Second Quarter 2025 Financial ResultsJuly 31 at 4:01 PM | prnewswire.comZynex Sets Second Quarter 2025 Earnings CallJuly 22, 2025 | prnewswire.comZynex (ZYXI) to Release Quarterly Earnings on WednesdayJuly 16, 2025 | marketbeat.comRoyal Bank Of Canada Issues Pessimistic Forecast for Zynex (NASDAQ:ZYXI) Stock PriceJuly 15, 2025 | marketbeat.comZynex: New CEO Steven Dyson shares his vision – ICYMIJuly 12, 2025 | proactiveinvestors.comZynex: New CEO Steven Dyson shares his vision – ICYMIJuly 12, 2025 | proactiveinvestors.comZynex Shareholder Sues Board, Execs Over Insurer’s Payment PauseJuly 11, 2025 | news.bloomberglaw.comNZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJuly 10, 2025 | globenewswire.comZynex CEO Thomas Sandgaard discusses leadership transition - ICYMIJuly 5, 2025 | proactiveinvestors.comZynex says Tricare payment suspension to remain in placeJuly 3, 2025 | msn.comZynex stock falls after Tricare extends payment suspensionJuly 2, 2025 | uk.investing.comTricare Temporary Payment Suspension UpdateJuly 2, 2025 | prnewswire.comZynex appoints Steven Dyson as new CEOJune 30, 2025 | msn.comZynex taps Steve Dyson as chief executive officerJune 30, 2025 | proactiveinvestors.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUEEC, ZYXI, TELA, and MYO Company DescriptionsMyomo NYSEAMERICAN:MYO$1.87 -0.06 (-3.11%) Closing price 08/1/2025 04:10 PM EasternExtended Trading$1.88 +0.01 (+0.59%) As of 08/1/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.TELA Bio NASDAQ:TELA$1.86 +0.16 (+9.41%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.86 0.00 (0.00%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.United Health Products OTCMKTS:UEEC$0.08 -0.01 (-8.57%) As of 08/1/2025 03:05 PM EasternUnited Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.Zynex NASDAQ:ZYXI$1.26 -0.97 (-43.50%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.27 +0.01 (+1.19%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
